BLS Pharmaceuticals Limited Stock
Stocks
BXN
AU000000BXN6
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.9400 AUD | +1.08% |
|
-1.05% | +123.81% |
| Market Cap | 213M 148M 129M 119M 111M 210M 14.07B 1.43B 554M 6.92B 555M 543M 23.83B | P/E 2024 |
-0.72x | P/E 2025 | 17.8x |
|---|---|---|---|---|---|
| Enterprise Value | 207M 144M 125M 115M 107M 204M 13.66B 1.38B 538M 6.72B 539M 527M 23.15B | EV / Sales 2024 |
1.03x | EV / Sales 2025 | 2.82x |
| Free-Float |
43.81% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +1.08% | ||
| 1 week | -1.05% | ||
| Current month | +1.08% | ||
| 1 month | +20.51% | ||
| 3 months | +46.88% | ||
| 6 months | +129.27% | ||
| Current year | +123.81% |
| 1 week | 0.9 |  | 0.96 |
| 1 month | 0.82 | | 1.1 |
| Current year | 0.36 | | 1.1 |
| 1 year | 0.33 | | 1.1 |
| 3 years | 0.04 | | 1.1 |
| 5 years | 0.04 | | 1.1 |
| 10 years | 0.04 | | 1.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sam Watson
CEO | Chief Executive Officer | - | 19/05/2023 |
Guy Robertson
DFI | Director of Finance/CFO | 72 | 01/09/2016 |
Jason Hine
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Peng Ho
CHM | Chairman | 67 | 05/12/2012 |
Guy Robertson
BRD | Director/Board Member | 72 | 30/06/2022 |
Sam Watson
BRD | Director/Board Member | - | 19/05/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-14 | Buy | 5,000,000 | 0.2202% | |||
| 05-14 | Fiscal year | 5,000,000 | 0.2202% | |||
| 03-22 | Buy | Chief Executive Officer | 1,800,000 | 0.0804% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.08% | -1.05% | +135.00% | +394.74% | 146M | |
| +1.70% | +7.41% | +3.12% | +8.46% | 49.15B | |
| +0.92% | +3.93% | +399.71% | +605.33% | 40.23B | |
| +1.89% | +8.32% | +26.06% | -6.35% | 34.55B | |
| +2.38% | +6.35% | +21.25% | +64.58% | 33.09B | |
| +3.96% | +10.67% | +11.89% | +38.86% | 25.19B | |
| +2.51% | +5.27% | - | - | 17.05B | |
| +2.58% | +5.79% | +73.44% | +133.27% | 15.92B | |
| +0.32% | +0.58% | +13.67% | +19.09% | 13.83B | |
| -1.14% | +1.88% | +15.30% | -28.79% | 13.26B | |
| Average | +1.62% | +5.18% | +77.71% | +136.58% | 24.24B | |
| Weighted average by Cap. | +1.81% | +6.31% | +87.50% | +131.91% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 9.64M 6.69M 5.85M 5.37M 5.01M 9.5M 637M 64.5M 25.07M 313M 25.1M 24.56M 1.08B | 29.28M 20.31M 17.75M 16.31M 15.21M 28.84M 1.93B 196M 76.14M 950M 76.22M 74.59M 3.28B |
| Net income | -13.33M -9.24M -8.08M -7.42M -6.92M -13.13M -880M -89.13M -34.65M -433M -34.69M -33.94M -1.49B | 4.9M 3.4M 2.97M 2.73M 2.55M 4.83M 324M 32.78M 12.74M 159M 12.76M 12.48M 548M |
| Net Debt | -318K -220K -193K -177K -165K -313K -20.97M -2.12M -826K -10.31M -827K -809K -35.52M | -6.13M -4.25M -3.72M -3.42M -3.19M -6.04M -405M -41.03M -15.95M -199M -15.97M -15.63M -686M |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/07/26 | A$0.9400 | +1.08% | 70,496 |
| 01/07/26 | A$0.9300 | 0.00% | 0 |
| 30/06/26 | A$0.9300 | -1.06% | 0 |
| 29/06/26 | A$0.9400 | -1.05% | 0 |
| 26/06/26 | A$0.9500 | 0.00% | 0 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BXN Stock
Select your edition
All financial news and data tailored to specific country editions
